1h Free Analyst Time
Haemonetics Corp (HAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions
- Corporate strategy - Analyst’s summarization of the company’s business strategy
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats
- Company history - Progression of key events associated with the company
- Major products and services - A list of major products, services and brands of the company
- Key competitors - A list of key competitors to the company
- Key employees - A list of the key executives of the company
- Executive biographies - A brief summary of the executives’ employment history
- Key operational heads - A list of personnel heading key departments/functions
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history
Highlights
Haemonetics Corp (Haemonetics) is a healthcare company that offers blood management technologies and software solutions. The company's portfolio includes integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite of solutions to the blood supply chain, which ranges from plasma and blood collectors to hospitals. Haemonetics markets its products to blood collection groups and independent blood centers, national health organizations, hospital service providers, hospitals, group purchasing organizations, and biopharmaceutical companies through a direct sales force and independent distributors. It has subsidiaries in the Americas, Asia, and Europe. Haemonetics is headquartered in Boston, Massachusetts, the US.Haemonetics Corp Key Recent Developments
May 10, 2022: Haemonetics 4th Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations WebsiteApr 06, 2022: Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2022 Results: May 10, 2022
Mar 21, 2022: Haemonetics Appoints James D'Arecca Chief Financial Officer
Feb 08, 2022: Haemonetics 3rd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
Nov 09, 2021: Haemonetics Announces CFO William P. Burke's Retirement for June 2022
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned
A selection of companies mentioned in this report includes:
- Werfen Life Group SAU
- Terumo BCT Inc
- Rotem
- Medtronic Plc
- MacoPharma SA
- LivaNova PLC
- Fresenius SE & Co KGaA
- Diagnostica Stago SAS